Lv3
352 积分 2026-03-09 加入
Exploratory mediation analysis of the effect of semaglutide on cardiovascular outcomes in people with overweight or obesity in the SELECT randomised trial
1天前
已关闭
MASLD, MASH, and the CKM Spectrum
12天前
已完结
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
12天前
已完结
Chronic Inflammation as an Overlooked Link between Cardiovascular and Kidney Disease
12天前
已完结
763-P: Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of a Dual GLP-1/GIP Receptor Agonist (HRS9531) in Healthy Subjects—A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose (SAD and MAD) Study
17天前
已关闭
New Generation Anti-Obesity Pharmacotherapy: Companion or Competitor to Metabolic bariatric Surgery?
17天前
已完结
Treatment of obesity: will incretin agonists make bariatric surgery a thing of the past?
17天前
已完结
Impact of Preoperative Weight Loss on 30-Day Complication Rate after Bariatric Surgery
17天前
已完结
Preoperative weight loss is linked to improved mortality and leaks following elective bariatric surgery: an analysis of 548,597 patients from 2015–2018
17天前
已完结
Early Adjuvant Treatment with Semaglutide After Sleeve Gastrectomy in Patients with Class II-III Obesity: A Prospective Non-Randomized Controlled Study
17天前
已完结
皖公网安备34019202002308
